US equities |
SPCX $168.50 ▲+6.00% NVDA $237.33 ▲+1.44% MU $1,066.33 ▼-0.80% TSLA $378.84 ▲+2.23% MSFT $525.49 ▲+1.54% SNDK $1,714.47 ▼-0.32% INTC $117.14 ▼-1.83% META $743.14 ▲+2.07%
FinancialContent

Alector, Inc. - Common Stock (NQ:ALEC)

2.191 +0.381 (+21.04%)
Delayed Quote Updated: 1:13 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alector, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Alibaba, Standard Lithium, Anterix And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Nasdaq Composite gaining 100 points on Friday. Here are some big stocks recording gains in today’s session. Lifezone Metals Limited (NYSE: LZM) surged 27.4% to... 
Via Benzinga
Topics Stocks
News headline image
Analyst Expectations for Alector's Future ↗
 
Via Benzinga
News headline image
How The Same Treatments May Work For Multiple Neurodegenerative Diseases ↗
Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate. 
Via Talk Markets
News headline image
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
Data readout expected in Q4 2024 
From Alector, Inc.
Via GlobeNewswire
News headline image
Expert Ratings for Alector ↗
 
Via Benzinga
News headline image
Preview: Alector's Earnings ↗
 
Via Benzinga
News headline image
Analyst Expectations for Alector's Future ↗
 
Via Benzinga
News headline image
Alector to Participate in Upcoming Healthcare Conferences
From Alector, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Alector Reduces Workforce To Support Recent Reprioritizing Plans ↗
 
Via Benzinga
News headline image
Analyst Expectations for Alector's Future ↗
 
Via Benzinga
News headline image
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Host Mid-Year Earnings Conference Call
Call Scheduled for Thursday, August 3, 2023, at 4:30 p.m. ET/1:30 p.m. PT 
From Alector, Inc.
Via GlobeNewswire
News headline image
7 Stocks That AI Says Will Make You a Millionaire by 2025 ↗
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio. 
Via InvestorPlace
News headline image
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in the BofA Securities 2023 Healthcare Conference
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in Upcoming Healthcare Conferences
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in Upcoming Healthcare Conferences
From Alector, Inc.
Via GlobeNewswire
News headline image
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Announces Promotion of Clare Hunt to Chief People Officer
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Alector, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >